Journal
NATURE GENETICS
Volume 51, Issue 1, Pages 151-+Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41588-018-0270-1
Keywords
-
Categories
Funding
- Bloodwise [15001]
- Cancer Research UK
- Kay Kendall Clinical Training Fellowship
- MRC/Leuka Clinical Training Fellowship
- MRC [MR/M009157/1, MR/P019609/1] Funding Source: UKRI
Ask authors/readers for more resources
Acute myeloid leukemia (AML) is a heterogeneous disease caused by a variety of alterations in transcription factors, epigenetic regulators and signaling molecules. To determine how different mutant regulators establish AML subtype-specific transcriptional networks, we performed a comprehensive global analysis of cis-regulatory element activity and interaction, transcription factor occupancy and gene expression patterns in purified leukemic blast cells. Here, we focused on specific subgroups of subjects carrying mutations in genes encoding transcription factors (RUNX1, CEBP alpha), signaling molecules (FTL3-ITD, RAS) and the nuclear protein NPM1). Integrated analysis of these data demonstrates that each mutant regulator establishes a specific transcriptional and signaling network unrelated to that seen in normal cells, sustaining the expression of unique sets of genes required for AML growth and maintenance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available